UK markets open in 2 hours 4 minutes

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.46+0.27 (+5.20%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts9999
Avg. Estimate-0.33-0.3-1.23-1.58
Low estimate-0.5-0.81-1.86-2.27
High estimate-0.160.23-0.62-0.99
Year ago EPS-0.32-0.32-0.71-1.23
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts9999
Avg. Estimate17.41M22.64M72.24M69.59M
Low estimate12M4.3M48.6MN/A
High estimate21.51M70.8M119.1M116.05M
Year ago sales17.79M16.37M100.36M72.24M
Sales growth (year/est)-2.10%38.30%-28.00%-3.70%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS-0.48-0.5-0.35-0.32
Actual EPS-0.32-0.32-0.26-0.3
Difference0.160.180.090.02
Surprise %33.30%36.00%25.70%6.30%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.33-0.3-1.23-1.58
7 days ago-0.34-0.31-1.24-1.57
30 days ago-0.34-0.3-1.25-1.58
60 days ago-0.37-0.33-1.31-1.66
90 days ago-0.37-0.33-1.32-1.67
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2121
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCTMXIndustrySector(s)S&P 500
Current qtr.-3.10%N/AN/AN/A
Next qtr.6.30%N/AN/AN/A
Current year-73.20%N/AN/AN/A
Next year-28.50%N/AN/AN/A
Next 5 years (per annum)-0.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A